Tapestry Pharmaceuticals, Inc. – February 1, 2006 (February 6th, 2006)
Reference hereby is made to that certain Purchase Agreement, dated as of even date herewith (the Purchase Agreement), by and among Tapestry Pharmaceuticals, Inc. (the Company) and each of the Investors party thereto (the Investors). Terms used but not otherwise defined herein shall have the meaning set forth in Purchase Agreement.
Tapestry Pharmaceuticals, Inc. – Contract (February 6th, 2006)
THE SECURITIES REPRESENTED HEREBY MAY NOT BE TRANSFERRED UNLESS (I) SUCH SECURITIES HAVE BEEN REGISTERED FOR SALE PURSUANT TO THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE SECURITIES ACT), (II) SUCH SECURITIES MAY BE SOLD PURSUANT TO RULE 144(K) OF THE SECURITIES ACT, OR (III) THE COMPANY HAS RECEIVED AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO IT THAT SUCH TRANSFER MAY LAWFULLY BE MADE WITHOUT REGISTRATION UNDER THE SECURITIES ACT OR QUALIFICATION UNDER APPLICABLE STATE SECURITIES LAWS.
Tapestry Pharmaceuticals, Inc. – Asset Purchase Agreement (August 28th, 2003)
This Asset Purchase Agreement (this "Agreement") is entered into on August 25, 2003, between Faulding Pharmaceutical Co., a Delaware corporation ("Buyer"), and NaPro BioTherapeutics, Inc., a Delaware corporation ("Seller"). Buyer and Seller are each referred to in this Agreement as a "Party" and collectively as the "Parties."
Tapestry Pharmaceuticals, Inc. – Employment Agreement (April 1st, 2002)
THIS AGREEMENT (the "Agreement") is entered into effective as of this 1st day of October, 2001 (the "Effective Date"), by and between NaPro BioTherapeutics, Inc., a Delaware corporation (the "Company"), and Leonard P. Shaykin ("Executive"). Certain capitalized terms used in this Agreement have the meaning set forth in Paragraph 17 of this Agreement.